Literature DB >> 12652453

The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia.

Peter Y Hahn1, Andrew H Limper.   

Abstract

Pneumocystis carinii remains an important cause of pneumonia in immunosuppressed hosts. Severe Pneumocystis pneumonia is characterized by an intense neutrophilic inflammatory response resulting in gas exchange abnormalities, diffuse alveolar damage, and respiratory failure. The inflammatory response directed against P. carinii involves a complex series of interactions between alveolar macrophages, CD4+ T lymphocytes, polymorphonuclear cells, and their various products. CD4+ T lymphocytes are crucial to host defense against P. carinii. Alveolar macrophages also provide essential functions that significantly enhance clearance of P. carinii infection. In addition, host proteins play an important role in augmenting the host inflammatory responses to this organism. Although essential for effective clearance of infection, excessive inflammatory responses also predispose the host to the development of lung injury and respiratory compromise. Understanding the complex processes involved in the host inflammatory response and its potential for causing lung injury may enable development of novel therapeutic approaches for this and other important fungal lung infections. Copyright 2003 Elsevier, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12652453     DOI: 10.1053/srin.2003.50004

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  9 in total

1.  Chitinases in Pneumocystis carinii pneumonia.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Med Microbiol Immunol       Date:  2012-04-26       Impact factor: 3.402

2.  CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice.

Authors:  Steve D Swain; Nicole N Meissner; Allen G Harmsen
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Myeloid dendritic cells (DCs) of mice susceptible to paracoccidioidomycosis suppress T cell responses whereas myeloid and plasmacytoid DCs from resistant mice induce effector and regulatory T cells.

Authors:  Adriana Pina; Eliseu Frank de Araujo; Maíra Felonato; Flávio V Loures; Claudia Feriotti; Simone Bernardino; José Alexandre M Barbuto; Vera L G Calich
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

4.  Primary alveolar epithelial cell surface membrane microdomain function is required for Pneumocystis β-glucan-induced inflammatory responses.

Authors:  Scott E Evans; Theodore J Kottom; Richard E Pagano; Andrew H Limper
Journal:  Innate Immun       Date:  2012-02-14       Impact factor: 2.680

Review 5.  Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-06

6.  Survival after Pneumocystis jirovecii pneumonia requiring ventilation: A case report.

Authors:  Gladness Nethathe; Nirav Patel
Journal:  South Afr J HIV Med       Date:  2016-10-31       Impact factor: 2.744

7.  A Clinically Applicable Nomogram for Predicting the Risk of Invasive Mechanical Ventilation in Pneumocystis jirovecii Pneumonia.

Authors:  Rongjun Wan; Lu Bai; Yusheng Yan; Jianmin Li; Qingkai Luo; Hua Huang; Lingmei Huang; Zhi Xiang; Qing Luo; Zi Gu; Qing Guo; Pinhua Pan; Rongli Lu; Yimin Fang; Chengping Hu; Juan Jiang; Yuanyuan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-03-10       Impact factor: 5.293

8.  Combination Immunotherapy with Passive Antibody and Sulfasalazine Accelerates Fungal Clearance and Promotes the Resolution of Pneumocystis-Associated Immunopathogenesis.

Authors:  Zachary Hoy; Terry W Wright; Michael Elliott; Jane Malone; Samir Bhagwat; Jing Wang; Francis Gigliotti
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

Review 9.  Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Rheumatology (Oxford)       Date:  2012-09-22       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.